These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 69792)

  • 1. Spectrum of thyroid function in patient's remaining in remission after antithyroid drug therapy for thyrotoxicosis.
    Irvine WJ; Gray RS; Toft AD; Seth J; Lidgard GP; Cameron EH
    Lancet; 1977 Jul; 2(8030):179-81. PubMed ID: 69792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM; Schimmel M; Utiger RD
    J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid function in patients in clinical remission after medical treatment of thyrotoxicosis.
    Hooper MJ; Ratcliffe JG; Ratcliffe WA; Spencer CA; McLarty DG; Alexander WD
    J Clin Endocrinol Metab; 1975 May; 40(5):807-11. PubMed ID: 47864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
    Martino E; Pinchera A; Capiferri R; Macchia E; Sardano G; Bartalena L; Mazzanti F; Baschieri L
    J Clin Endocrinol Metab; 1976 Sep; 43(3):543-9. PubMed ID: 821960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid function in the long-term follow-up of patients treated with iodine-131 for thyrotoxicosis.
    Toft AD; Irvine WJ; Seth J; Hunter WM; Cameron EH
    Lancet; 1975 Sep; 2(7935):576-8. PubMed ID: 51406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid function and histology in forty-five patients with hyperthyroid Graves' disease in clinical remission more than ten years after thionamide drug treatment.
    Hirota Y; Tamai H; Hayashi Y; Matsubayashi S; Matsuzuka F; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):165-9. PubMed ID: 2415549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of HLA and thyroid antibodies with clinical course of thyrotoxicosis treated with antithyroid drugs.
    Irvine WJ; Gray RS; Morris PJ; Ting A
    Lancet; 1977 Oct; 2(8044):898-900. PubMed ID: 72241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
    Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
    J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM
    Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG; Hershman JM; Chopra IJ; Levine GA; Pekary E; Geffner DL; Chua Teco GN
    J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient recurrence of hyperthyroidism after delivery in Graves' disease.
    Amino N; Miyai K; Yamamoto T; Kuro R; Tanaka F
    J Clin Endocrinol Metab; 1977 Jan; 44(1):130-6. PubMed ID: 576228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of the autonomously functioning thyroid nodule: the Walter Reed Army Medical Center experience, 1975-1996.
    Burch HB; Shakir F; Fitzsimmons TR; Jaques DP; Shriver CD
    Thyroid; 1998 Oct; 8(10):871-80. PubMed ID: 9827653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid function and intellectual development of infants nursed by mothers taking methimazole.
    Azizi F; Khoshniat M; Bahrainian M; Hedayati M
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3233-8. PubMed ID: 10999814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid function after surgical treatment of thyrotoxicosis. A report of 100 cases treated with propranolol before operation.
    Toft AD; Irvine WJ; Sinclair I; McIntosh D; Seth J; Cameron EH
    N Engl J Med; 1978 Mar; 298(12):643-7. PubMed ID: 628387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.
    Peterson ME; Melián C; Nichols R
    J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism.
    Stott DJ; McLellan AR; Finlayson J; Chu P; Alexander WD
    Q J Med; 1991 Jan; 78(285):77-84. PubMed ID: 1670067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.